Accretion Nutraveda
ANL •BSE

Accretion Nutraveda

₹329.0018.00 (5.79%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
305.00
Today’s high
333.00
52 week low
150.10
52 week high
348.00
Open price
305.00
Previous close
311.00
Live volume
16,000
Lower circuit
263.20
Upper circuit
394.80

Fundamentals

Market Cap
₹225Cr
ROE
18.45%
P/E Ratio(TTM)
0.00
EPS(TTM)
0.00
P/B Ratio
6.35
Dividend Yield
0.00%
Industry P/E
50.89
Book Value
49.00
Debt to Equity
0.20
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
2026
₹33.72Cr
+110.62%
₹5.07Cr
+102.66%
010203040
2023
2024
2025
2026
Revenue growthValue
3Y CAGR+122%
Profit growthValue
3Y CAGR+162%

About

Accretion Nutraveda functions as a CDMO (Contract Development and Manufacturing Organisation). It combines traditional Ayurvedic principles with modern nutraceutical science to serve both domestic and international markets.;
CEO/MD
Mayur Popatlal Sojitra
Founded in
2021
BSE symbol
544694
Industry

Shareholding pattern

Jan '26
Feb '26
Mar '26
Jun '26
Sep '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,382.50
-38.90 (1.61%)
L
    H
    18,414.2127.165.46
    PfizerPFIZER
    ₹3,856.00
    -0.90 (0.02%)
    L
      H
      17,641.2420.534.2
      ₹6,373.50
      +79.50 (1.26%)
      L
        H
        15,737.2592.7818.03
        Natco PharmaNATCOPHARM
        ₹807.00
        +10.40 (1.31%)
        L
          H
          15,623.8013.651.49
          2026
          31
          Oct
          Quarterly Result
          Release date
          8
          May
          Annual Result
          Release date
          Events calendar
          View upcoming events in other stocks